A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

NCT07661641 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Prostate Cancer
Colorectal Cancer
GRPR-positive Solid Tumors

Interventions

DIAGNOSTIC_TEST: [68Ga]Ga-A9-6217
DIAGNOSTIC_TEST: Low dose [177Lu]Lu-A9-0631
DRUG: [177Lu]Lu-A9-0631
DRUG: [225Ac]Ac-A9-0642

Sponsor

Alpha-9 Oncology USA Inc.